, Castle Biosciences, Inc.

• SKIN The Journal of Cutaneous Medicine Vol. 3 No. 4 (2019) - Original Research
  Establishing an evidence-based decision point for clinical use of the 31-gene expression profile test in cutaneous melanoma
  Abstract  Full Article PDF
• SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Skin Cancer
  Recurrence prediction in cutaneous melanoma with 31-gene expression profiling and sentinel lymph node biopsy
  Abstract  Poster PDF
• SKIN The Journal of Cutaneous Medicine Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®) - Skin Cancer
  Development and validation of a nomogram incorporating the 31-GEP test and clinicopathologic factors for accurate prediction of recurrence risk in patients with cutaneous melanoma
  Abstract  Poster PDF
• SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Genomics and Precision Medicine
  A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients with High-Risk Cutaneous Squamous Cell Carcinoma (cSCC)
  Abstract  PDF
• SKIN The Journal of Cutaneous Medicine Vol. 2 No. 2 (2018) - Original Research
  Prospective, Multicenter Clinical Impact Evaluation of a 31-Gene Expression Profile Test for Management of Melanoma Patients
  Abstract  Full Article PDF